Close

Arena Pharma (ARNA) Bullish Thesis Intact - Jefferies

November 11, 2013 8:36 AM EST Send to a Friend
Jefferies analyst Thomas Wei reiterated a Buy rating and $12 price target on Arena Pharma (NASDAQ: ARNA) Monday following its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login